Document:

<PAGE>   1
                                  EXHIBIT 10.1

                        DNA SPECIMEN REPOSITORY AGREEMENT

         Agreement made this 21st day of June, 1995 between the UNIVERSITY OF
NORTH TEXAS HEALTH SCIENCE CENTER AT FORTH WORTH ("UNTHSC"), an entity of the
State of Texas located in Fort Worth, Texas, and GENELINK, INC. ("GeneLink"), a
Pennsylvania corporation, with its principal office located in Margate, New
Jersey.

         NOW, THEREFORE, in consideration of the premises hereinafter set forth,
the parties hereto mutually covenant and agree as follows:

         1. Purpose. GeneLink has originated a program to market DNA Collection
Kits(TM) ("Kits") by which an individual (the "Client") can obtain his or her
DNA specimens ("Specimens") which will then be preserved for 25 years and be
available for various DNA laboratory analysis from time-to-time. A Kit shall be
used by one individual Client to furnish Specimens of that one individual.
UNTHSC is willing to serve as the repository to receive and extract the
Specimens, preserve them for a period of 25 years and make them available for
analysis, on the terms set forth in this Agreement.

         2. Term.

                  2.1 GeneLink shall designate by notice to UNTHSC the
commencement date of this Agreement, which shall be when GeneLink commences the
sale of Kits and after GeneLink has paid the $13,600 referred to in Section 9.5
below ("Effective Date"). In no event shall the Effective Date be later than
April 30, 1996. Unless sooner terminated in the manner set forth below, the
primary term of this Agreement shall be for a period of five years after the
Effective Date, the parties shall negotiate a possible renewal of the Agreement,
but there shall be no obligation to renew.

                  2.2 The expiration or earlier termination of the term of this
Agreement shall relieve UNTHSC of the responsibility to continue to receive new
Specimens. It shall not relieve UNTHSC of the responsibilities to continue to
preserve Specimens already received by it for the full period of 25 years from
time of receipt of the Specimens, and to retrieve such Specimens for analysis,
as provided below, nor shall it relieve GeneLink of its obligations hereunder
with regard to such preserved Specimens; provided, however, that at any time
after the expiration or earlier termination of this Agreement GeneLink may
elect, at its expense, to transfer the Specimens to another repository, and
UNTHSC shall cooperate with GeneLink in arranging such transfer.

         3. Exclusivity.

                  3.1 Within the United States of America, UNTHSC agrees that it
will not during the term of this Agreement and for a period of one year after
termination of this Agreement, engage in any business or perform any service,
directly or indirectly, in competition with the business of GeneLink, or have
any interest, whether as proprietor, partner, stockholder, principal, agent,
consultant, or in any other capacity or manner whatsoever, in any enterprise
which shall so engage, but only to the extent that UNTHSC's purpose of such
interest is to provide long-term DNA specimen preservation services which is in
competition with the business of GeneLink. For purposes of this Section 3.1,
"business of GeneLink" shall not include the provision of analysis and
extraction of DNA, including, without limitation, the DNA analysis and
extraction services currently provided by UNTHSC. During the period of one year
after non-renewal, UNTHSC's only obligation under this Section shall be to
refrain from competing in association with those entities with which GeneLink is
doing business and which are listed by GeneLink in a notice to UNTHSC. UNTHSC
for any reason set forth in Section 4.1, then this Section shall have no effect
and UNTHSC shall not be bound by the noncompete clause incorporated herein.

                  3.2 During the term of this Agreement, GeneLink agrees not to
engage any entity other than UNTHSC to provide long-term preservation of
Specimens for GeneLink's clients.

         4. Termination.

                  4.1 Subject to Section 2.2 above, either party ("Terminating
Party") may elect immediately to terminate this Agreement prior to the end of
the term in the event that the other party ("Defaulting Party"): (1) dissolves,
disbands, or a liquidator or trustee is appointed or takes possession of the
Defaulting Party's property and such appointment or possession remains in effect
for more than 90 days; (2) is adjudicated bankrupt or insolvent or a petition is
filed against it under any bankruptcy law and is not dismissed within 90 days
after filing; (3) fails to account and/or make any payment due hereunder, and
such failure is not cured within 30 days after written notice is given; (4)
fails in any material and substantial manner to perform any other obligation
required of it hereunder and such failure is not cured within 30 days after
written notice thereof is given; or (5) is found by a court of competent
jurisdiction to have engaged in material acts of deceit or fraud, and all
applicable appeal periods have expired without any appeals being filed, or if
any appeals have been filed, a final, unappealable decision has affirmed such
finding.

                                       1
<PAGE>   2
                  4.2 Termination shall be effected by the Terminating Party
providing notice in accordance with this Agreement to the other party declaring
its election to terminate. Termination shall not affect any right of either
party which accrued prior to such termination. Termination shall be without any
further liability on the part of the Terminating Party. In the event of
termination under clause (1) or (2) of subsection 4.1, if no successor is
performing GeneLink's obligations under this Agreement, then GeneLink shall make
available to UNTHSC the names and addresses of each Client and his
identification number and his payment history, so that UNTHSC can identify
Clients requesting retrieval of Specimens.

         5. The Kits.

                  5.1 GeneLink shall furnish to UNTHSC prototype of any versions
of Kits that it puts into production from time-to-time, and UNTHSC shall
cooperate with GeneLink by promptly furnishing any comments with regard to such
prototypes. However, since the parties are independent contractors, the design,
appearance and specifications of the Kits shall be under the complete control
and responsibility of GeneLink, and UNTHSC shall have no responsibility
therefor, except as follows:

                      GeneLink may in its marketing of Kits state that the
                              Specimens shall be stored at repositories located
                              at UNTHSC and that quantitative extraction of the
                              Specimens shall be performed by UNTHSC, or words
                              to that effect. The parties agree that the
                              language set forth in Exhibit C attached hereto
                              and made a part hereof is an acceptable statement
                              for purposes of this section, and UNTHSC shall
                              cooperate with GeneLink in approving unreasonably
                              withheld or delayed. GeneLink shall obtain the
                              written approval of UNTHSC prior to using the name
                              of UNTHSC in its advertising, marketing,
                              distributing or selling of the Kits, or in any
                              other manner, other than as stated in this section
                              and Exhibit C, and Section 7.4.

                      UNTHSC shall approve in writing: (a) the specifications
                              for the implement which the Client shall use in
                              collecting the Specimen; (b) the Client
                              instructions included with the Kit; and (c) any
                              written instructions inclusive of the data from
                              furnished by GeneLink to the Client in connection
                              with retrieval of Specimens as described below,
                              which approvals shall not be unreasonably withheld
                              or delayed. GeneLink agrees that the Client
                              instructions or any data form included with the
                              Kit shall refer to the repository, the disposal of
                              Specimens at the end of the 25 years,
                              confidentiality of the Client's name, and a
                              statement that the Specimen may not be appropriate
                              for certain types of genetic analysis. If GeneLink
                              shall submit a specification or instruction in
                              writing to UNTHSC, UNTHSC shall have been deemed
                              to approve such specification or instruction
                              unless it notifies GeneLink in writing within 30
                              days after receipt thereof. The parties agree that
                              initially the specification for the swabs set
                              forth in Exhibit D attached hereto and made a part
                              hereof and the collection procedure described in
                              Exhibit A are approved by the parties.

         Unless otherwise agreed by the parties, each Kit shall contain 21 bar
                         coded labels, with an adhesive that is mutually
                         acceptable to the parties, which acceptance shall not
                         be unreasonably withheld or delayed.

         6. Full Requirements. In performing its services of collecting,
preserving and retrieving Specimens as provided herein, UNTHSC shall maintain
such staff and facilities as may be necessary to meet the full requirements of
GeneLink under this Agreement. The parties recognize that the program is a new
venture and that it is not possible to predict accurately the volume of
Specimens that may be received. The parties recognize that the success of
GeneLink's program will depend, in part, on the ability of UNTHSC to process,
and preserve and retrieve Specimens in whatever quantity GeneLink is able to
produce. GeneLink will cooperate with UNTHSC in advising UNTHSC on the first and
fifteenth of each month of the expected volume of Specimens, and UNTHSC shall be
responsible for process, preserving and retrieving under this Agreement whatever
quantity of Specimens is required by GeneLink to serve its Clients.

                  7. Collection Procedure.

                  7.1 GeneLink or the Client shall ship to UNTHSC the Specimens,
which shall contain a number for identification purposes. GeneLink shall
maintain the record of the Client name identified with each number, and UNTHSC
shall be furnished only the numbers for each Specimen.

                  7.2 UNTHSC shall furnish at the UNTHSC campus and shall
maintain during the term of this Agreement and for a period of 25 years from the
time the last Specimen is received pursuant to this Agreement, a repository
sufficient to store and

                                       2
<PAGE>   3
preserve all Specimens furnished pursuant to this Agreement and shall maintain
the repository in accordance with the following conditions:

                      Two separate freezers used to store Specimens shall be
                              kept at a minimum temperature of - 20(0)c. at all
                              times; provided, however, that UNTHSC may
                              designate another minimum temperature that will
                              prohibit bacteriological growth and maintain the
                              integrity of the Specimen, subject to the consent
                              of GeneLink, which consent shall not be
                              unreasonably withheld.

                      The Specimens shall be kept in a secured environment, with
                              an alarm system to notify UNTHSC security of
                              unauthorized entry or of any failure of freezer
                              temperature.

                      The repository shall be staffed on an 8 hour per day/40
                              hour per week basis. The repository shall be
                              closed in accordance with the holiday schedule and
                              emergencies declared by administration of UNTHSC.

                      UNTHSC shall maintain a data base for the repository
                              which shall contain information regarding receipt
                              and storage of all Specimens in accordance with
                              their identification number.

                  7.3 UNTHSC shall maintain computer contact with GeneLink for
quick and efficient communication.

                  7.4 UNTHSC shall provide to GeneLink written and pictorial
material describing the repository, UNTHSC and its personnel that shall be
suitable for promotional use by GeneLink if it should choose to do so, and
UNTHSC hereby authorized such use.

                  7.5 UNTHSC shall process Specimens received pursuant to this
Agreement within three working days of receipt.

                                       3
<PAGE>   4
                  7.6 Upon receipt of Specimen, UNTHSC shall:

                      Enter the identification number of the Specimens that it
                              receives into the repository data base immediately
                              upon receipt, and advise GeneLink thereof on a
                              daily basis.

                      Provide technicians and equipment necessary to extract the
                              DNA from the swabs in accordance with the
                              procedure set forth in Exhibit A hereto, which is
                              incorporated by reference into this Agreement.
                              UNTHSC may in writing from time-to-time adopt
                              other scientifically acceptable PROCEDURES THAT
                              ARE EQUIVALENT IN ACCURACY TO THE PROCEDURES SET
                              FORTH IN exhibit a, and shall advise GeneLink of
                              any such new procedure. In case of objection by
                              GeneLink, the parties shall meet and attempt to
                              resolve the matter. UNTHSC shall seek to extract
                              all available human specific DNA.

                      Preserve the Specimen (if at least 4,5000 nanograms of
                              human specific DNA), half in each of the two
                              freezers for a period of 25 years form the date of
                              receipt, and advise GeneLink on a daily basis of
                              the Specimens on that day placed in the freezers
                              and the semi-quantitative approximate of the total
                              quantity of DNA in each Specimen.

                  7.7 UNTHSC shall not be responsible for determining the length
of the DNA from a Specimen. both parties acknowledge that by not determining the
length of the DNA, certain analytical DNA procedures may not be able to be
performed.

                  7.8 In the event that the testing of the Specimen by UNTHSC
determines that a Client's Specimen does not yield at least 4,500 nanograms of
DNA, UNTHSC shall preserve the Specimen, notify GeneLink, and GeneLink shall
seek to obtain new Specimens from such Client to replace the initial Specimen.

                  7.9 Upon placing the Specimen in the freezer, and UNTHSC's
receipt of payment as provided herein, UNTHSC shall issue a certificate to be
sent to the Client by GeneLink which shall certify that UNTHSC is preserving the
Specimen in it repository for the 25 year period. The form of the certificate
shall be agreed to in writing form time-to-time by the parties. the parties
agree that initially the form attached hereto as Exhibit F shall be the form of
the certificate.

                  7.10 In the event that shipping instructions and payment of
reasonable shipping and handling costs have not been received by UNTHSC within
90 days after the expiration of the 25 year preservation period, UNTHSC shall,
at its sole option, ship within the Untied States at UNTHSC's cost, outdated
Specimens to a GeneLink location or subsequent repository as designated by
GeneLink, in group mailings at intervals to be determined by UNTHSC, or
otherwise discard the Specimens in accordance with applicable law.

         8. Retrieval and Analysis of Specimens.

                  8.1 GeneLink shall advise UNTHSC when a Client wishes to
retrieve Specimens for analysis and furnish a copy of the Client's consent. Such
consent shall conform with applicable state and federal law. Analysis shall be
performed at such laboratory as the Client shall designate. If UNTHSC shall have
the capability to perform such analysis, GeneLink will include UNTHSC on the
same basis as other qualified laboratories in whatever information about
specific testing laboratories, if any, GeneLink furnishes to the Client or its
representatives.

                  8.2 Upon being notified by GeneLink that a Client wishes to
access a Specimen, UNTHSC shall within three business days retrieve the
requested Specimens in accordance with the procedures set forth in Exhibit B
attached hereto and incorporated by reference to this Agreement; test the
Specimen for efficacy; package and send the appropriate portion of the Specimen
as directed by GeneLink; and return the unused portion of the Specimen to
storage.

                  8.3 The size of the portion of the Specimen to be removed
shall be determined by the testing laboratory authorized to perform the Client
order test.

                  8.4 UNTHSC does not guarantee and shall not be held
responsible for the number of genetic tests that can be performed on an
individual's stored DNA during the storage period.

                  8.5 GeneLink shall be responsible for collecting retrieval
fees from the Client and paying UNTHSC the appropriate fees prior to the
retrieval and testing of Specimens.

                  8.6 UNTHSC shall advise GeneLink on a daily basis of the
Specimens shipped to laboratories for analysis.

                                       4
<PAGE>   5
         9. Payment.

                  9.1 Subject to Section 9.6 below, on or before the 15th day of
each month of the term of this Agreement (or the next succeeding business day),
GeneLink shall pay UNTHSC [Confidential Information filed separately with the
Securities and Exchange Commission] per Client submitting Specimens to UNTHSC
during the previous month. Such payment shall constitute the entire fee for the
DNA extraction and 25 year storage of such Specimen by UNTHSC as provided
herein. Such payment shall be made by GeneLink without regard to the Client's
payment or non-payment to GeneLink.

                  9.2 At the time of each payment in accordance with Section
9.1, GeneLink shall also pay UNTHSC [Confidential Information filed separately
with the Securities and Exchange Commission] for or any Client submitting
additional Specimens to UNTHSC during the previous month in order to replace or
supplement deficient Specimens. Such payment shall constitute the entire fee for
the quantitative extraction and 25 year storage of such additional Specimens.
Such payment shall be made by GeneLink without regard to the individual's
payment or non-payment to GeneLink.

                  9.3 In the development of GeneLink's program, the selection of
collection materials and the development of the procedure for collection set
forth in Exhibit A, GeneLink has relied upon the advise and assistance of
UNTHSC. If an excessive number of Specimens, for whatever reason, do not contain
the required minimum amount of DNA, then UNTHSC shall work with GeneLink to
resolve the problem.

                  9.4 Prior to the Effective Date of this Agreement, GeneLink
shall pay to UNTHSC $13,600 to be used for the establishment of the
repositories, approximately as set forth on a capital expenses budget submitted
by UNTHSC to GeneLink prior to the date hereof. Any of such amount that is not
used by UNTHSC for such purpose, shall be returned to GeneLink.

                  9.5 As the sole method to repay such $13,600 advance, the
payments to UNTHSC in Section 9.1 of this Agreement shall be [Confidential
Information filed separately with the Securities and Exchange Commission] for
the first 5,667 individuals submitting original Specimens. In the event that a
portion of the advance is returned to GeneLink pursuant to Section 9.4, the
number of individuals specified in this Section shall decrease proportionally so
that the amount of repayment equals the advance amount actually used by UNTHSC.

                  9.6 For UNTHSC's services in retrieving Specimens for analysis
in accordance with exhibit B, GeneLink shall pay UNTHSC a retrieval fee of
[Confidential Information filed separately with the Securities and Exchange
Commission] per Specimen retrieved. In addition to the retrieval fee, UNTHSC
shall be paid [Confidential Information filed separately with the Securities and
Exchange Commission] per daily shipment to a particular laboratory for handling
the shipment, and GeneLink shall be responsible for the actual shipping charge
and out-of-pocket cost of packaging material. Payments under this Section shall
be on the same terms as specified in Section 9.1.

                  9.7 If, after the expiration of the term or the earlier
termination to this Agreement, Specimens are sent by Clients to UNTHSC, UNTHSC
will forward the Specimens as directed by GeneLink, and GeneLink shall pay the
same amounts as applicable for shipment of Specimens under Section 9.6.

         10. Notices. All notices required hereunder shall be sufficient only if
in writing and shall be deemed to have been given if delivered (including by
nationally recognized overnight delivery service) or mailed by certified mail,
return receipt requested, postage prepaid, or by facsimile (receipt confirmed):

                           If to GeneLink, addressed to:

                                            P.O. Box 3212
                                            100 S. Thurlow Avenue
                                            Margate, NJ 08402
                                            Attn:  Mr. John R. DePhillipo
                                            Fax No.:  (609) 823-6616

                           with a copy to:

                                            Steven J. Serling, Esquire
                                            Pelino & Lentz, P.C.
                                            One Liberty Place, 32nd Floor
                                            1650 Market Street
                                            Philadelphia, PA 19103-7393

                                       5
<PAGE>   6
                                            Fax No.:  (215) 665-1536

                           if to UNTHSC, addressed to:

                                            University of North Texas Health
                                            Science Center at Fort Worth
                                            35 Camp Bowie Boulevard
                                            Fort Worth, TX 76107
                                            Attn:  Mr. Dennis Shingleton
                                            Fax No.:  (817) 735-2424

or such other address as the party to receive the notice shall advise by due
notice hereunder. Notices shall be effective the earlier of receipt or five days
after dispatch.

         11. Independent Contractor. This Agreement is not intended as and shall
not be construed as a brokerage agreement or an agreement of joint venture or
partnership or of employment by either party of the other or of its employees.
UNTHSC shall perform all work and services hereunder as an independent
contractor and shall not be an officer, agent, servant or employee of GeneLink.
UNTHSC shall have exclusive control, and the exclusive right to control, the
details of the work and services performed hereunder, and all persons performing
same. Neither UNTHSC nor GeneLink shall incur any indebtedness, enter into any
undertaking or make any commitment in the other party's name or purporting to be
on the other party's behalf except with the express written permission of the
other party.

         12. Standard and Care.

                  12.1 The services to be provided by UNTHSC hereunder shall be
diligently performed with UNTHSC's ordinary and prudent skill and attention and
in conformity with this Agreement and its various exhibits and with the level of
skill appropriate for the preservation and testing of DNA material. without
limiting the foregoing, UNTHSC agrees to be reasonable for all Specimens lost or
damaged while in its possession or control.
GeneLink shall use due care in the performance of its obligations hereunder.

                  12.2 To the extent permitted by the laws of Texas, UNTHSC
agrees to indemnify and hold harmless GeneLink, its officers, directors,
shareholders and employees from any and all demands, actions, suits, claims,
liability, damage, cost or expense, that arise out of or in connection with the
performance by UNTHSC of its duties hereunder, except for and to the extent of
any action or inaction of GeneLink, its officers or employees, or agents.

                  12.3 GeneLink agrees to indemnify and hold harmless UNTHSC,
its Board of Regents, officers and employees from any and all demands, actions,
suits, claims, liability, damage, cost or expense, that arise out of or in
connection with the development, manufacturing, advertising, marketing,
distribution, sale, use or misuse of the Kits, whether arising out of the acts
or omissions of GeneLink, its officers, employees or agent, or otherwise, except
for and to the extent of any action or inaction of UNTHSC, its officers or
employees, or agents.

         13. Confidential Information.

                  13.1 It is understood that in the performance of its services
under this Agreement, UNTHSC may have access to private or confidential
information of Clients. UNTHSC shall use its best efforts to keep, and have its
employees and agents keep, any and all such information confidential and to use
such information only for the purposes of fulfilling its services under this
Agreement or otherwise as agreed to by the Client. this provision shall not
prohibit UNTHSC from disclosing such information to persons required to have
access thereto for the performance of this Agreement, or pursuant to a
requirement of applicable federal or state law.

                  13.2 UNTHSC recognized the exclusive right of GeneLink in and
to all of the trademarks of GeneLink applied to the Kits, the GeneLink program,
and the services furnished by GeneLink hereunder and any and all of GeneLink's
copyrights of material used in connection therewith. UNTHSC acknowledges that
the system and procedures utilized by GeneLink in performing the services under
this Agreement may contain commercially valuable proprietary confidential
materials utilized by GeneLink in marketing its products are confidential
information and trade secrets which may be disclosed to UNTHSC on a confidential
basis pursuant to this Agreement. UNTHSC shall have no copyright interest,
patent rights, property rights or other interest in the services provided by
GeneLink hereunder or in any developments or improvements thereto (other than
laboratory procedures developed by UNTHSC that do not involve proprietary
material of GeneLink), whether or not presently existing, nor in any software
programs which may be developed by GeneLink to perform its services hereunder.
UNTHSC agrees to hod confidential and to use only in connection with the
services provided under this Agreement all proprietary information GeneLink
furnishes to UNTHSC, which shall have been marked "confidential" or
"proprietary." UNTHSC's obligations under this Section shall not apply to any
information that was known to UNTHSC prior to disclosure by GeneLink, or is or
becomes generally available to the public other than

                                       6
<PAGE>   7
by breach of this Agreement or is required to be disclosed in accordance with
applicable federal or state law.

                  13.3 In any academic publication describing its activities
under this Agreement or findings based thereon, UNTHSC shall refer to and
identify GeneLink as the provider of the GeneLink program.

         14. Authority. Each party to this Agreement represents to the other
that it has the full right, power and authority to enter into and perform this
Agreement in accordance with all of the terms, provisions, covenants and
conditions thereof, and that the execution and delivery of this Agreement has
been duly authorized by proper corporate or Board of Regents action.

         15. Representation of UNTHSC. UNTHSC represents to GeneLink that, based
on UNTHSC's reasonable and prudent professional judgment, based on its
experience in working with DNA and on certain testing procedures it has employed
as described on Exhibit E attached hereto and made a part hereof, UNTHSC is not
currently aware of any scientifically accepted reason why the procedures
described in Exhibits A and B are not appropriate procedures for the purpose of
the collection and extraction of DNA; why DNA Specimens collected, preserved and
retrieved in accordance with such procedures and this Agreement should not
survive for at least 25 years or why stored Specimens should not result in
Specimen material appropriate in quality and quantity for DNA analysis by
independent commercial laboratories to identify various types of DNA related to
diseases or medical conditions.

         16. Force Majeure Clause. The parties hereto are relieved of any
liability if unable to meet the terms and conditions of this Agreement due to
any "Act of God", riots, epidemics, strikes, or any act or order which is beyond
the control of the party not in compliance; provided that it takes all
reasonable steps practical and necessary to effect prompt resumption of its
responsibilities hereunder.

         17. Non-Waiver. The failure of either party to insist upon the
performance of any term or provision of this Agreement or to exercise any right
herein conferred shall not be construed as a waiver or relinquishment of the
party's right to assert or rely upon any such term or right on any future
occasion.

         18. Assignability and Benefit. UNTHSC shall not assign its obligations
or rights hereunder. Any unauthorized assignment or delegation by UNTHSC of its
rights or duties hereunder, without the prior written consent of GeneLink, shall
b void and shall constitute a breach of this Agreement. GeneLink shall not
assign its obligations or rights hereunder without the consent of UNTHSC, which
consent shall not be unreasonably withheld or delayed (except that GeneLink may
assign to an entity controlled by or under common control with GeneLink). The
covenants herein contained shall bind and the benefits and advantages shall
inure to the respective successors and permit assignees of the parties, jointly
and severally.

         19. Compliance with Applicable Laws. Each party shall be responsible
for obtaining and maintaining at its sole expense and in its name, all licenses
and permits which such party may require in order to perform the services
described herein. UNTHSC and GeneLink shall each comply with all applicable
federal, state and local laws and regulations respectively applicable to each
party in connection with the services contemplated hereunder. both parties
represent that they have no actual knowledge that any federal, state or other
governmental regulatory approvals are required prior to the execution or
effectiveness of this Agreement. All obligations under this Agreement are
subject to any future required federal, state or other city regulatory
approvals. Each party shall use good faith efforts to obtain any such approvals
which are required because of that party's identity, status or actions, and the
other party or parties shall cooperate with any such efforts. If any such
approvals are required but not obtained, then, subject to the provisions of the
following sentence, the obligations to which such approvals apply shall have no
force or effect until such time or times as the required approvals are obtained.
If the unenforceability of any such obligations materially and substantially
diminishes the considerations which otherwise would be received by any party
under this Agreement, than that party may terminate this Agreement without
liability in accordance with Section 4 of this Agreement.

         20. Severability. In the event that any provision hereof shall be
deemed in violation of any law or held to be invalid by any court in which this
Agreement shall be interpreted, the violation or invalidity of any particular
provision shall not be deemed to affect any other provision hereof, but this
Agreement shall be thereafter interpreted as though the particular provision so
held to be in violation or invalid were not contained herein.

         21. Entirety Clause. This written agreement constitutes the entire
agreement of the parties regarding the subject matter of this Agreement.
Statements or representations not included herein shall not be binding upon the
parties, and no subsequent modifications or amendments of any of the terms
hereof shall be valid or binding unless made in writing and signed by both
parties.

         22. State Law and Venue. This Agreement shall be construed under the
laws of the State of Texas. the parties consent to the venue of the federal
district court for the Northern District of Texas with respect to legal actions
concerning this Agreement, or, if such court does not have jurisdiction, the
courts of Tarrent County, Texas.

         IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the 21st day of June, 1995.

                                       7
<PAGE>   8
                                           GENELINK, INC.

       June 21, 1995                /s/ John R. DePhillipo
     -----------------              -----------------------------------------
         Date                               John R. DePhillipo
                                            President and CEO

                                            UNIVERSITY OF NORTH TEXAS HEATH
                                   SCIENCE CENTER AT FORT WORTH

                                            By: /s/ David M. Richard, D.O.
                                               ------------------------------
                                            President

                                       8<PAGE>   1
                                  EXHIBIT 10.2

                               AMENDMENT NO. 1 TO
                                   AGREEMENTS
                                     BETWEEN
                                 GENELINK, INC.
                                       AND
                 UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
                                 AT FORTH WORTH

         1. PARTIES. This AMENDMENT is made and entered into by and between
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORTH WORTH, whose address is
3500 Camp Bowie Blvd., Forth Worth, Texas 76107-2699, hereinafter referred to as
"UNTHSC", and GENELINK, INC., a Pennsylvania corporation, with its principal
office located in Margate, New Jersey, hereinafter referred to "GeneLink".

         2. AMENDED AGREEMENTS. This is an Amendment to the DNA Specimen
Repository Agreement by and between the above listed parties dated June 21,
1995, hereinafter referred to as "AGREEMENT". A copy of the AGREEMENT is
attached hereto and incorporated by reference. In addition, this is an Amendment
to the Collateral License Agreement by and between the above listed parties
dated July 1, 1996, hereinafter referred to as "LICENSE AGREEMENT". A copy of
the LICENSE AGREEMENT is attached hereto and incorporated by reference.

         3. AMENDMENT DATE. This AMENDMENT is effective on April 1, 1996.

         4. AMENDMENT. In accordance with Section 21 of the AGREEMENT and
Section 1 of the LICENSE AGREEMENT, and for good and valuable consideration,
GeneLink and UNTHSC hereby make the following amendments:

         SECTIONS 9.1 AND 2.1 of the AGREEMENT shall be modified as follows:

                  GeneLink shall continue to pay UNTHSC (***) per client for a
                  period of 5 years beyond the date of termination of the
                  AGREEMENT on March 21, 2001. On or about April 1, 2005, the
                  parties shall negotiate in good faith a possible adjustment of
                  this fee based upon current technology and costs. Absent a
                  written agreement signed by both parties adjusting this
                  resulting from such negotiation, all kits sold under the terms
                  of the AGREEMENT will be stored by UNTHSC in accordance with
                  the terms of the AGREEMENT at the rate of (***) per sample
                  through March 30, 2006.

         SECTION 2 of the LICENSE AGREEMENT shall be replaced with the
         following:

                  This LICENSE AGREEMENT shall be for the term of the AGREEMENT
                  and for the term of the AMENDMENT effective on April 1, 1996,
                  through March 30, 2006, and any other subsequent extensions.
                  This LICENSE AGREEMENT shall be subject to termination upon
                  the conditions of the AGREEMENT.

         5. CONFLICT. Other than the matters addressed above, this AMENDMENT
does not act to change or alter any other provision of the AGREEMENT or the
LICENSE AGREEMENT. In the event of a conflict between the terms of this
AMENDMENT and the AGREEMENT, the terms of this AMENDMENT will control. In the
event of a conflict between the terms of this AMENDMENT and the LICENSE
AGREEMENT, the terms of this AMENDMENT will control.

UNIVERSITY OF NORTH TEXAS           GENELINK, INC.
HEALTH CENTER AT FORT WORTH

By: /s/ David M. Richard, D.O.                 By: /s/John R. DePhillipo
   -------------------------------                ---------------------------
   David M. Richard, D.O.                          John R. DePhillipo
   President                                       President and CEO

Date:    November 11, 1996                     Date:  November 5, 1996

                                       1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]